News

October 7, 2019October 7, 2019

Diet Low in Fermented Sugars May Ease IBD Symptoms, Study Reports

News

A diet that is low in fermented sugars may help alleviate symptoms of inflammatory bowel disease (IBD), a study suggests. The study, “Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, ... Read more

October 4, 2019October 4, 2019

2 Microbiome-Based Potential Therapies for IBD Enter Early Testing, Biomica Announces

News

Biomica announced the start of preclinical studies to test the anti-inflammatory abilities of two of its microbiome-based therapies for inflammatory bowel disease (IBD). The company’s potential microbe treatments aim to restore ... Read more

October 2, 2019October 2, 2019

Entyvio Seen as Superior to Humira in Treating Active UC, Phase 3 Trial Shows

News

One year of treatment with Entyvio (vedolizumab) was found to be superior to Humira (adalimumab) in achieving disease remission in people with ulcerative colitis (UC), a common form of inflammatory bowel disease (IBD), Takeda ... Read more

September 30, 2019September 30, 2019

Galapagos NV Launching Phase 1 Trial for Dual Action Anti-inflammatory Molecule

News

Galapagos NV‘s potential new therapy for inflammatory bowel disease (IBD) — which stimulates anti-inflammatory signals while inhibiting pro-inflammatory ones — will move into Phase 1 clinical testing, the company announced. ... Read more

September 27, 2019September 27, 2019

Innate Biologics Granted Patent for Modified Anti-inflammatory Bacterial Proteins

News

Innate Biologics has been granted a U.S. patent for its bacterial protein-based anti-inflammatory technology, the company announced in a press release. The technology is based off of bacterial E3 ubiquitin ... Read more

September 25, 2019September 25, 2019

PD-L2 a Potential Target to Prevent Inflammation in Crohn’s Disease, Study Reveals

News

Inhibition of the signals triggered by a molecule called PD-L2 may prevent activation of autoimmunity in the gut and the progression of Crohn’s disease, a preliminary study suggests. “This study ... Read more

September 23, 2019September 23, 2019

Patient Groups in British Columbia Criticize Mandatory Switch to Biosimilars in IBD

News

A collaboration of Canadian patient organizations said British Columbia’s (BC) decision to switch those with inflammatory bowel disease (IBD) to biosimilar drugs is short-sighted and a breach of conventional patient-physician ... Read more

September 20, 2019September 20, 2019

Innovation Pharma Planning 1st Clinical Trial of Oral Brilacidin as Potential Ulcerative Colitis Treatment

News

Innovation Pharmaceuticals is planning a first clinical trial of an oral formulation of Brilacidin as a treatment for ulcerative colitis (UC), one of the most common types of inflammatory bowel disease (IBD). Brilacidin ... Read more

September 18, 2019September 17, 2019

FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for IBD

News

The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits of ... Read more

September 13, 2019September 13, 2019

Human Microbiome Project Reveals Causes of Disrupted Gut in IBD Patients

News

Differences in molecular events in the gut contribute to the disrupted microbiome and flare-ups in patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, according to a ... Read more